Narayana Hrudayalaya (NH) Fundamentals 2026 — P/E 49.7x, Revenue Analysis | SniperIQ
Narayana Hrudayalaya (NH) is a India-listed Healthcare company in Medical - Care Facilities with a market capitalization of ₹39,965 Crore, trading at ₹1967.80 on the BSE. This SniperIQ fundamentals page covers Narayana Hrudayalaya's valuation (P/E 49.7x, P/B 8.8x), profitability (net margin 10.2%), revenue (₹7,896 Crore in FY2026), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Narayana Hrudayalaya's market cap?
Narayana Hrudayalaya (NH) has a market capitalization of approximately ₹39,965 Crore, trading at ₹1967.80 on the BSE. Market cap moves with the live share price.
What is Narayana Hrudayalaya's P/E ratio?
Narayana Hrudayalaya's trailing twelve-month P/E ratio is 49.7x, with a price-to-book (P/B) of 8.8x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Narayana Hrudayalaya?
Narayana Hrudayalaya runs a net profit margin of 10.2%, a gross margin of 41.4%, and an operating margin of 20.0%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Narayana Hrudayalaya generate?
Narayana Hrudayalaya reported revenue of ₹7,896 Crore for fiscal year 2026, with net income of ₹806 Crore and earnings per share (EPS) of 39.67. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Narayana Hrudayalaya pay a dividend?
Narayana Hrudayalaya offers a trailing dividend yield of about 0.2%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Narayana Hrudayalaya financially healthy?
Narayana Hrudayalaya carries a debt-to-equity ratio of 1.29x and a current ratio of 2.15x, with a market beta of -0.03. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Narayana Hrudayalaya a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Narayana Hrudayalaya (NH) the key facts are: market cap ₹39,965 Crore, P/E 49.7x, revenue ₹7,896 Crore, 52-week range 1296.4-2371.6. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Narayana Hrudayalaya's full fundamentals live
Get Narayana Hrudayalaya's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.